Abstract Although Alzheimer's dementia (AD) is not characterised any longer simply as the accumulation and deposition of amyloid beta (Ab) peptides and hyperphosphorylation of tau proteins within the brain, excessive Ab 42 deposition is still considered to play a major role in this illness. Ab are able to adopt many differently aggregate forms, including amyloid fibrils as well as nonfibrillar structures (soluble Ab 42 oligomers). It is not well-established that which Ab 42 state is most responsible for AD or why. We wanted to verify which effects Ab 42 oligomers and aggregated peptides have on gene expression, protein level and enzyme activity of insulin and amyloid precursor protein (APP) pathways in vitro. Human neuroblastoma cells (SH-SY5Y) were treated with varying concentrations of soluble and aggregated Ab 42 . Treatment effects on b-secretase (BACE), glycogen synthase kinase 3a (GSK3a), glycogen synthase kinase 3b (GSK3b), phosphatidylinositol-3 kinase (PI-3K), insulin-degrading enzyme (IDE), insulin-receptor substrate 1 (IRS1), insulin receptor (INSR) and monoamine oxidase B (MAO-B) were investigated via quantitative-PCR, western blot, ELISA and enzyme activity assay. We could find different effects of soluble and aggregated peptides especially on gene/protein expression of GSK3b and INSR and on GSK3b and MAO-B activity. Soluble peptides showed significant effects leading to increased gene expression and protein amount of GSK3b and to decreased level of gene and protein expression of INSR. MAO-B activity was enhanced after treatment with aggregated peptides and strongly inhibited after soluble Ab 42 treatment. Our data might provide insights into selective effects of specific forms of Ab 42 aggregates in AD.
Introduction
Alzheimer's dementia (AD) is not characterised any longer as simply the accumulation and deposition of amyloid beta (Ab) peptides and hyperphosphorylated tau proteins within the brain; in the meantime, it has also been characterised by synaptic loss (Small 2004) , imbalanced metabolism (Schindowski et al. 2008; Grünblatt et al. 2010 ), abnormal protein cross-linking (Munch et al. 1998; Wang et al. 2008) , and disturbance of the insulin-signalling pathway (Hoyer et al. 1994; de la Monte et al. 2009; Riederer et al. 2010) . There are two types of AD that differ in the fact that one is an early onset AD, also called familial AD (FAD), which is genetically based, while the other is a late onset AD (LOAD), which is a sporadic form and probably involves both polygenetic and environmental factors like expression of apolipoprotein E allele e4 (ApoEe4), hypertension, diabetes mellitus, hyperlipidemia, hyperhomocysteinemia, coronary and peripheral artery diseases, alcohol, smoking, obesity, levels of physical or mental activity, levels of education, and environmental exposures (reviewed in (Barnes et al. 2010; Isik 2010) . FAD accounts for approximately 5 % of all AD cases and leads to an earlier onset of the disease at around 45 years of age. Genes involved in FAD codes for amyloid precursor protein (APP) (Muller and Zheng 2012) , presenilin 1 (PS1) and presenilin 2 (PS2), which are involved in increased Ab 42 production as well as in decreased Ab 42 degradation. Although more and more factors are found to be involved in AD, excessive Ab 42 deposition is still considered to play a major role in AD. However, the mechanisms that contribute to abnormal Ab 42 accumulation are not fully understood (Benilova et al. 2012) , both increased production and decreased degradation have been observed (Crouch et al. 2008) . Ab 42 are able to adopt many differently shaped aggregates including amyloid fibrils (Glabe 2008) as well as nonfibrillar aggregates that are also termed soluble Ab 42 ''oligomers'' (Haass and Selkoe 2007) . It is not wellestablished that which Ab 42 state is most responsible for AD or why. Recent evidence strongly implicates Ab 42 oligomers as the proximal pathogenic trigger (De Felice et al. 2008) . These oligomers are markedly elevated in the brain and cerebrospinal fluid of postmortem AD patients and appear to play a critical role in the synaptic failure and memory deficits of early AD (Klyubin et al. 2008) . It is therefore important to determine directly whether neurons exposed to oligomers undergo pathological changes characteristic of the AD brain. In the current study, we sought to verify the effects of oligomers and aggregated Ab 42 peptides on gene expression, protein level and enzyme activity in vitro. The cell culture model chosen for this investigation was the human SH-SY5Y neuroblastoma cell line. These cells show the most common neurobiochemical (e.g., enzymes like dopamine b-hydroxylase, acetylcholintransferase, etc., and neurotransmitters like dopamine, adrenaline, acetylcholine, GABA) and neurobiological factors (e.g., dopamine transporter and receptors, GABAergic receptors, etc.) (Biedler et al. 1978; Ross et al. 1983 ) and can be perfectly used as an experimental model to study the effects of Ab 42 oligomers and aggregated Ab 42 peptides. Our main focus lay on treatment effects on b-secretase (BACE), glycogen synthase kinase 3a (GSK3a), glycogen synthase kinase 3b (GSK3b), phosphatidylinositol-3 kinase (PI-3K), insulin-degrading enzyme (IDE), insulinreceptor substrate 1 (IRS1), insulin receptor (INSR) and monoamine oxidase B (MAO-B). They are all already known to be involved in the pathology of AD: BACE is the first protease in the processing of APP leading to the production of Ab 42 in the brain; therefore, it is one recent target for therapeutic treatment of AD (Ghosh et al. 2011) . Over-activity of GSK3 accounts for memory impairment, tau hyperphosphorylation, increased Ab 42 production and local plaque-associated microglial-mediated inflammatory responses, all of which are hallmark characteristics of AD (reviewed in Hooper et al. 2008) . PI-3K has been identified as second messenger system providing anti-apoptotic signal to various cell types (Brunet et al. 2001 ). In addition, neuroprotection against extracellular Ab 42 toxicity is dependent on PI-3K pathway (Zhang et al. 2003; Lesne et al. 2005) . IDE is a metalloprotease that, apart from insulin, also binds and degrades other substrates, including Ab 42 ; therefore, reduced IDE activity diminishes Ab 42 clearance and contributes to the formation of senile plaques (Mukherjee et al. 2000) . (Zhao et al. 2009 ). MAO-B activity is significantly increased in AD patients (Gotz et al. 1998; Grünblatt et al. 2005 ) and inhibition of MAO-B has a neuroprotective effects for AD (reviewed in Riederer et al. 2004 ).
Materials and methods

Cell culture
SH-SY5Y cells were bought from European Collection of Cell Cultures and grown in buffered Dulbecco's modified Eagle medium (DMEM/F-12) (Pan Biotech GmbH, Aidenbach, Germany) supplemented with 10 % fetal bovine serum and 0.1 % gentamycin (50 mg/ml) (Life technologies, Darmstadt, Germany) in a humidified incubator (5 % CO 2 ) at 37°C.
Preparation of soluble and aggregated Ab 42
The preparation of the Ab 42 peptide was modified according to Dahlgren et al. (2002) . Five-hundred microgram of freeze-dried Ab 42 (Millipore, Schwalbach, Germany) was dissolved in 1,1,1,3,3,3 hexafluoroisopropanol (HFIP) to a concentration of 1 mM and incubated for 1 h at room temperature. Subsequently, the HFIP was removed using a vacuum centrifuge and the peptide film was dissolved in dry dimethyl sulfoxide (DMSO) to a final concentration of 5 mM. For aggregated Ab 42 peptides, the solution was diluted with 10 mM HCl and stored for 7 days in the incubator at 37°C. The test concentrations of both the soluble and the aggregated Ab 42 were finally diluted with normal cell-culture medium.
Cell treatment with Ab 42
For Western blot (WB), enzyme-linked immunosorbent assay (ELISA), fluorescent ELISA and quantitative realtime polymerase chain reaction (QRT-PCR), SH-SY5Y cells were treated with varying concentrations of soluble and aggregated Ab 42 (see ''Preparation of soluble and aggregated Ab 42 '') (0, 5, 1, 2,5 and 10 lM), or purified DMSO or HCl as a control, by adding it in the right concentration to the culture medium. The reaction was stopped after 48 h and cells were trypsinized for further investigations.
Cytotoxicity
To determine a possible toxic effect of Ab 42 on the cells, the CytoTox-Glo TM test from Promega (Mannheim, Germany) was performed. For testing the cytotoxicity effect, 10,000 cells/ml per well were cultivated for 24 h at 37°C in 5 % CO 2 saturation in the incubator, so that the cells could adhere to the bottom of the wells. Afterwards, cells were treated with soluble or aggregated Ab 42 in a concentration of 0.1, 0.5, 1, 2, 3, 5, 10, 20, 50 and 100 lM. Reaction was measured 48 h later.
RNA extraction and QRT-PCR
Total RNA was extracted from SH-SY5Y cells using the RNeasy Plus MiniKit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Total RNA (500 ng) was reverse transcribed using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Munich, Germany). QRT-PCR was performed using an iCycler iQ TM Real Time PCR Detection System (Bio-Rad) and the SYBR-Green detection method. The QRT-PCR reaction was optimized according to the manufacturer's instructions. QuantiTech Primer assays for b-actin (ACTB; QT00193473), glyceraldehyde-3-phosphate dehydrogenase (GAPDH, QT01192646), ribosomal protein L13A (RPL13A; QT00089915), peptidylprolyl isomerase A (PPIA, QT01866137), b-secretase (BACE, QT00084777), glycogen synthase kinase 3a (GSK3a, QT00075306), glycogen synthase kinase 3b (GSK3b, QT00057134), phosphatidylinositol-3 kinase (PI-3K, QT00035175), insulindegrading enzyme (IDE, QT00080773), insulin-receptor substrate 1 (IRS1, QT00074144) and insulin receptor (INSR, QT00082810) were purchased from Qiagen (Hilden, Germany). ACTB, GAPDH, RPL13A and PPIA were used for normalization according to GeNorm (Vandesompele et al. 2002) . The amplified transcripts were quantified using the comparative threshold cycle (Ct) analysed using the BioRad iCycler iQ program.
Western blot
Western blotting was used to detect changes in the protein levels of Insulin receptor (IR) b subunit in SH-SY5Y cells. To determine the total protein amount of each sample, Bradford protein assay was conducted (Sigma-Aldrich, Schorndorf, Germany). Samples (50 lg of total protein, denatured with dithiothreitol) were separated on 4-12 % Bis-Tris gel and transferred onto nitrocellulose membranes (Life technologies, Darmstadt, Germany). Protein of interest was detected using its specific antibodies: rabbit anti-IRb (antibody) (1:250, Santa Cruz, Heidelberg, Germany). Following blocking the membrane for 1 h at room temperature (5 % blocking milk in TBS-Tween), and afterwards, incubation with primary antibody at 4°C overnight, membranes were incubated with HRP conjugated secondary antibody (1:15.000, Sigma-Aldrich, Schorndorf, Germany) for 1 h at room temperature. The IRb protein immunoreactive bands were detected using the enhanced chemiluminescence (ECL) detection plus system from GE Healthcare (Freiburg, Germany) and quantified using ImageJ software without modifying picture properties (e.g., gain, colour or contrast). For comparison, the values of b-actin, as a housekeeping protein, were used. The membranes were stripped to remove the attached antibodies. It was followed by 1-h incubation in 5 % BSA blocking solution at room temperature. The murine b-actin antibody (1:5000, Santa Cruz, Heidelberg, Germany) was already linked with HRP and was detected and quantified like IRb protein.
Enzyme-linked immunosorbent assays
The Invitrogen (Darmstadt, Germany) GSK-3b kit is a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) and was used to detect and quantify the level of total GSK-3b protein and of GSK-3b protein phosphorylated at serine residue 9. Samples were prepared according to manual. Detected protein amount was normalised with total protein amount of used samples, as detected via Bradford protein assay (Sigma-Aldrich, Schorndorf, Germany).
Enzyme activity MAO-B enzyme activity was measured using Amplex red monoamine oxidase assay kit (Life technologies, Darmstadt, Germany). 50 lg of total protein (detected via Bradford protein assay) of homogenised SH-SY5Y cells was diluted in reaction buffer and varying concentrations of soluble and aggregated Ab 42 (see ''Preparation of soluble and aggregated Ab 42 '') (0.5, 1, 2.5 and 10 lM) were added. After 30-min incubation at 37°C, 100 ll substrate (the specific MAO-B substrate-benzylamine hydrochloride) mix was added and again incubated for 1 h at 37°C. The endpoint measurement was done in a fluorescence multi plates meter (Novostar) at an excitation of 542 nm and an emission of 590 nm.
Statistical analysis
Statistical analyses of the WB, ELISA and QRT-PCR data were performed using StatView for Windows (SAS 
Results
Soluble and aggregated species of Ab 42 were prepared as described above and controlled via electron microscopy (shown in supplementary figure 1 ). Avoiding neural cell death, we tested a wide range of Ab 42 lM doses (0-100 lM) before cell treatment and used just the nontoxic range from 0-10 lM for this study. Concentration of over 20 lM aggregated Ab 42 showed significant cell toxicity, while for soluble form only a trend to toxicity was observed (supplementary figure 2).
Gene expression
BACE, GSK3a, GSK3b, PI-3K, IDE, IRS-1 and INSR were the investigated genes. After gene expression analysis, we could detect two genes with significant differences between treated and untreated cells. GSK3b was significantly upregulated after cell treatment with 1 and 2 lM (?362 % p \ 0.05; ?357 p \ 0.05) of soluble Ab 42 and we could detect a tendency of higher gene expression after treatment with 1, 2, 5 and 10 lm of the aggregated Ab 42 (Table 1) . The second gene revealing statistically significant results was the INSR. Treatment with 5 and 10 lM of soluble peptides tended to result in a lower INSR gene expression compared to untreated cells while, on the other hand, treatments with 1 lM of the aggregated peptides tended to result in a higher expression and treatment with 5 and 10 lM even led to a significant overexpression of INSR (?183 p \ 0.05; ?201 p \ 0.05; Table 1 ). Based on these results we further investigated the protein expression of these two genes to examine whether the differences influence gene transcription.
Protein level
After SH-SY5Y cells were treated with all doses of soluble Ab 42 , significantly higher GSK3b protein levels (30-45 %) were detectable compared to the control cells (p \ 0.01, Fig. 1a) , which confirms the gene expression data of GSK3b. Treatments with aggregated peptides did not show any significant effects on GSK3b total protein levels in any of the used doses (Fig. 1a) . Because GSK3b is a kinase enzyme that, when phosphorylated at serine residue 9 becomes inactive, we investigated the phosphorylated form of this protein to affirm whether it is more or less active after Ab 42 treatment to the cells. We calculated the ratio between the total amount of GSK3b protein and its phosphorylated form, which represents the enzyme activity (Fig. 1b) . Remarkably, the total protein amount of GSK3b was not only found to be statistically and significantly increased after treatment with soluble peptides, but there was also a significant detectable enhancement of the enzyme activity under this condition (145-231 % more activity in all used dosages compared to untreated cells, 0.01 \ p \ 0.05; Fig. 1b) . On the other hand, the enzyme activity did not alter after treatment with aggregated peptides (Fig. 1b) . The gene expression data of INSR demonstrated already a tendency for reduced expression after treatment with soluble peptides (Table 1) , which resulted in significantly decreased total amount of IRb after treatment with 0.5, 1 and 2 lM of soluble Ab 42 (50-60 % less total IRb protein amount compared to untreated cells, p \ 0.05; Fig. 2 ). On the other hand, in the gene expression analysis, a significant over-expression of INSR after treatment with aggregated peptides was observed (Table 1) , which was confirmed only at 1 lM aggregated peptide treatment for the total IRb protein expression. At 1 lM of aggregated Ab 42 we could detect 60 % more IRb compared to control cells (p \ 0.05; Fig. 2 ).
Enzyme activity MAO B enzyme activity was significantly reduced after cell homogenate treatment with 1, 2, 5 and 10 lM of soluble Ab 42 peptides (18-30 % less activity, p \ 0.01; Fig. 3 ). In contrast, the aggregated peptides enhanced the enzyme activity with significant results at 1, 2 and 5 lM of aggregated peptide (30-40 % more activity compared to control, p \ 0.01; Fig. 3 ).
Discussion
Alzheimer's dementia is the most frequent form of dementia in the elderly with an increasing incidence in the aging population in industrialised countries in the next decades. Thus, the investigation of associations between risk factors, possible genetic candidate genes and influences of other disease like T2DM on AD, is of major interest. Although increasing factors are found to be involved in AD, excessive Ab 42 deposition is still considered to play a major role in this disease, and so the presented study used the neuroblastoma cell line SH-SY5Y to determine directly whether neurons exposed to Ab 42 peptides undergo pathological changes characteristic of AD brain, and what influences they have on genes and proteins involved in the insulin signalling pathway and in the APP pathway. In general, it is accepted that the oligomeric form of Ab 42 causes synapse dysfunction, including tau hyperphosphorylation, calcium dysregulation and oxidative stress blockade of fast axonal transport altered turnover of neuronal receptors involved in synaptic plasticity, and synapse loss, the molecular and cellular mechanisms underlying their toxicity are still poorly understood and need further clarification (Mucke 2012; Sebollela et al. 2012) . In particular, we have observed a strong influence of the soluble form of Ab 42 peptides on GSK3b gene expression as well as on its protein level and activity. It has been already postulated that GSK3b activity might exert a central role in the development of AD (Hooper et al. 2008) . GSK3b activity was implicated in tau phosphorylation, APP processing, Ab 42 production and neurodegeneration (Balaraman et al. 2006; Hooper et al. 2008) . Our finding of increased GSK3b gene/protein expression and activity points to the fact, that GSK3b might be a crucial element in the Ab 42 -triggered molecular cascade leading to potential neurodegeneration. The observed effect of Ab 42 oligomers Fig. 1 Total protein amount of glycogen synthase kinase 3b (GSK3b) and ratio of phosphorylated GSK3b/total GSK3b after SH-SY5Y treatment with soluble and aggregated Ab 42 peptides. a The percentage of the mean values of total amount of the protein measured by a sandwich ELISA. b The percentage of the mean values of total amount of the protein and of phosphorylated protein amount measured by a sandwich ELISA. Reference value (100 %) is control group with untreated SH-SY5Y cells. For the statistical analysis ANOVA, post-hoc Scheffé with a specified significance level of p \ 0.05 was used. *p \ 0.05, **p \ 0.01 versus control. The sample size was n = 6-12 (Townsend et al. 2007; Zhao et al. 2009 ). Normally, activation of INSR leads to the phosphorylation of PI 3-kinase, which leads to an activation of AKT. Once active, AKT enters the cytoplasm where it leads to the phosphorylation and inactivation of GSK3b (Jolivalt et al. 2008 (Bartl et al. 2012) . Not only an impairment of INSR leads to an activation of GSK3b as explained before but also the oxidative stress can enhance the activity of this kinase (Hernandez and Avila 2008) . Riederer et al. (2004) already reviewed the link between oxidative stress and AD, especially regarding the increased MAO-B activity. MAO-B is a flavin-containing enzyme localised in the outer mitochondrial membrane and is responsible for the oxidative deamination of neurotransmitters (noradrenaline, dopamine and serotonin) and exogenous amines. During its catalytic activity, it produces hydrogen peroxide formed in the reaction, which is a possible source for oxidative stress. Highlighting more the possible link between Ab 42 , GSK3 and MAO-B we analyzed the effect of soluble and aggregated peptides on MAO-B enzyme activity. Interestingly, the soluble oligomers inhibited the enzyme activity significantly, but the aggregated forms of Ab 42 peptides, which are more similar to the amyloid plaques within the brain, enhanced the MAO-B activity in a dose dependent manner. Although we could find an inhibition of MAO-B activity after soluble peptide treatment, it cannot be concluded that these oligomers might be neuroprotective. An increased MAO-B activity was found in senile plaques (Saura et al. 1997 ) and in platelets of AD patients (Gotz et al. 1998) , therefore, our results of enhanced MAO-B activity following treatment with aggregated while not with soluble Ab 42 peptides, might indicate the involvement of the fibrillar structures of Ab 42 in the oxidative stress cascade known to play an important role in AD (Grünblatt et al. 2005 (Grünblatt et al. , 2010 . To our knowledge, this is the first report indicating the direct influence of soluble or aggregated peptides on MAO-B activity in vitro. Our data affirm that there has to be a neurobiochemical link between MAO-B and Ab 42 . In conclusion, our results suggest that Ab 42 oligomers seem to be more involved in cellular mechanisms linked to AD, except in enhancement of MAO-B activity, than the aggregated Ab 42 peptides, which is confirmed with the actual literature. AD seem to involve numerous mechanisms such as amyloid plaque formation, tau hyperphosphorylation, apoptosis, impairment of insulin signalling pathway and oxidative stress, causing neurodegeneration, which means that further investigations are necessary to enlighten the molecular mechanism of AD pathogenesis.
